Table 1.
Ref. | Number of patients lost to follow up (5) | Nature of study | Standardisation for comorbidities |
Chu et al[12] | 17 (6.9) | Prospective | Standardised |
Larrson et al[7] | 0 | Prospective | Not standardised |
Schleiffer et al[23] | 0 | Prospective | Standardised |
Faglia et al[20] | 0 | Prospective | Standardised |
Van Damme et al[13] | 0 | Prospective | Standardised |
Goldner et al[5] | NS | Prospective | Standardised |
Morbach et al[16] | 0 | Prospective | Standardised |
Ghanassia et al[8] | 5 (5) | Prospective | Standardised |
Skoutas et al[10] | 0 | Prospective | Standardised |
Adler et al[24] | 155 (2) | Prospective | Standardised |
Ohsawa et al[25] | 0 | Prospective | Standardised |
Izumi et al[9] | N/A | Retrospective | Standardised |
Murdoch et al[6] | N/A | Retrospective | Standardised |
Uzzaman et al[26] | N/A | Retrospective | Standardised |
Acar et al[11] | N/A | Retrospective | Standardised |
Nerone et al[17] | N/A | Retrospective | Standardised |
Aulivola et al[27] | N/A | Retrospective | Not standardised |
Jeyaraman et al[18] | N/A | Retrospective | Standardised |
Jeyaraman et al[21] | N/A | Retrospective | Standardised |
Thorud et al[15] | N/A | Meta-analyses | Standardised |
Albers et al[28] | N/A | Meta-analyses | Standardised |
Borkosky et al[14] | N/A | Systematic Review | Standardised |
NS: Not specified; N/A: Not applicable.